ComPASS Collective for Community Engagement (C3E)

ComPASS 社区参与集体 (C3E)

基本信息

批准号：
10903370
负责人：
Gordon R Bernard
金额：
$ 70万
依托单位：
VANDERBILT UNIVERSITY MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-11 至 2024-02-29
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10903370
关键词：
Academy Address Applications Grants Archives Area Automobile Driving Biomedical Research COVID-19 Chronic Disease Clinical Research Clinical and Translational Science Awards Communities Community Developments Complex Data Ensure Equity Exclusion Foundations Funding Future Goals Health Sciences Healthcare Hybrids Infrastructure Institution Internet Intervention Knowledge Measures Medicine Methodology Methods Minority-Serving Institution Mission Modeling Multi-Institutional Clinical Trial National Center for Advancing Translational Sciences National Institute on Minority Health and Health Disparities Needs Assessment Patient-Focused Outcomes Pharmaceutical Preparations Policies Public Health Informatics RADx Recommendation Research Research Infrastructure Research Institute Research Personnel Resource Development Resources Review Literature Role Science Series Summary Reports System Translational Research Translations United States National Institutes of Health Voice community based participatory research community engaged research community engagement community organizations community partnership design health equity health inequalities improved informatics tool innovation marginalization marginalized population meetings multidimensional data novel operation pragmatic trial prevent programs response science and society skills success tool trial design

项目摘要

The Vanderbilt Institute for Clinical and Translational Research (VICTR) is a highly functional and integrated clinical and translational (C&T) research infrastructure that has raised the quality and scientific rigor of the research conducted at Vanderbilt and longstanding partner Meharry, the nation's oldest historically black academic health science institution. VICTR will contribute to the mission of the CTSA program while leveraging unique resources and expertise within VICTR's Hub and elevating the role of health equity in C&T research with these new aims: 1) Leverage VICTR's strong collaborative energy to enhance team science methodologies, integrate community engagement principles for all stages of research, and implement programs designed to support health equity in research; 2) Develop and share multi-dimensional data organization methods and informatics tools to promulgate innovation, efficiency, quality, and equity in research; 3) Ensure the translational science workforce is diverse and has the skills, knowledge, and resources necessary to advance translation of discoveries within a health equity framework; 4) Support the efficiency, quality, representativeness, and impact of local studies and `raise the bar' for acceptable scientific standards in research conduct; 5) Support the efficiency, quality, representativeness, and impact of multi-site clinical trials by building and disseminating streamlining programs and promoting novel trial designs; and 6) Utilize unique institutional capabilities to enable the conduct of pragmatic trials during healthcare operations and repurpose existing drugs for new indications.

范德比尔特临床和转化研究所（VICTR）是一个高度功能的综合临床和转化（C＆T）研究基础设施，提高了质量和在范德比尔特（Vanderbilt）和长期合作伙伴梅哈里（Meharry）进行的研究的科学严谨国家历史上最古老的黑人学术健康科学机构。 Victr将有助于 CTSA计划的任务同时利用Victr的独特资源和专业知识集线器和提高健康公平在C＆T研究中的作用，以这些新目标：1）利用维克特（Victr）强大的协作能量，以增强团队科学方法论研究的各个阶段的社区参与原则，并实施设计计划支持研究中的健康公平； 2）开发和共享多维数据组织颁布研究的创新，效率，质量和公平性的方法和信息学工具； 3）确保转化科学劳动力多样化，并具有技能，知识和在健康公平框架内推进发现的必要资源； 4）支持本地研究的效率，质量，代表性和影响，并“提高标准” 对于可接受的研究行为科学标准； 5）支持效率，质量，通过建立和传播多站点临床试验的代表性和影响简化程序并促进新颖的试验设计； 6）利用独特的机构能够在医疗保健操作期间进行务实试验的能力并重新利用现有的药物以进行新的适应症。